NASDAQ: KRYS
Krystal Biotech Inc Stock Ownership - Who owns Krystal Biotech?

Insider buying vs selling

Have Krystal Biotech Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
John Charles ThomasEVP General Counsel2026-06-251,000$179.25
$179.25kBuy
John Charles ThomasEVP General Counsel2026-06-251,000$347.27
$347.27kSell
Krish S. KrishnanPresident and CEO2026-06-04640$302.24
$193.43kSell
Krish S. KrishnanPresident and CEO2026-06-04320$300.75
$96.24kSell
Suma KrishnanPresident RD2026-06-04240$311.65
$74.80kSell
Suma KrishnanPresident RD2026-06-042,039$310.94
$634.00kSell
Suma KrishnanPresident RD2026-06-042,801$309.95
$868.16kSell
Suma KrishnanPresident RD2026-06-043,803$308.89
$1.17MSell
Suma KrishnanPresident RD2026-06-0412,729$307.81
$3.92MSell
Suma KrishnanPresident RD2026-06-041,348$307.10
$413.96kSell

1 of 13

KRYS insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when KRYS insiders and whales buy or sell their stock.

KRYS Shareholders

What type of owners hold Krystal Biotech Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Fmr LLC14.78%4,373,987$1.42BInstitution
Blackrock Inc13.31%3,940,456$1.28BInstitution
Krish S. Krishnan10.84%3,208,408$1.05BInsider
Suma Krishnan10.84%3,208,408$1.05BInsider
Avoro Capital Advisors LLC9.76%2,888,888$941.14MInstitution
Vanguard Portfolio Management LLC4.92%1,456,727$474.57MInstitution
State Street Corp4.44%1,314,434$428.22MInstitution
Vanguard Capital Management LLC3.94%1,165,324$379.64MInstitution
Soleus Capital Management LP3.90%1,153,087$375.65MInstitution
Capital World Investors2.79%824,720$268.68MInstitution

1 of 3

KRYS vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
KRYS79.66%20.34%Net SellingNet Selling
CYTK90.50%9.50%Net SellingNet Selling
ABVX63.37%0.00%
HALO77.81%22.19%Net SellingNet Selling
APGE95.77%4.23%Net SellingNet Selling

Krystal Biotech Stock Ownership FAQ

Who owns Krystal Biotech?

Krystal Biotech (NASDAQ: KRYS) is owned by 95.84% institutional shareholders, 24.47% Krystal Biotech insiders, and 0.00% retail investors. Krish S. Krishnan is the largest individual Krystal Biotech shareholder, owning 3.21M shares representing 10.84% of the company. Krish S. Krishnan's Krystal Biotech shares are currently valued at $1.05B.

If you're new to stock investing, here's how to buy Krystal Biotech stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.